Pulse Biosciences, Inc. reported $751K of revenue over the trailing twelve months. 9 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $751K (to Q1 2026). Net Income: −$75M, trailing twelve months to Q1 2026. Free Cash Flow: −$55M, trailing twelve months to Q1 2026.

PLSEPulse Biosciences, Inc.

HealthcareUSD

$48.07

$12.6652 weeks$50.45

PLSE as reported

Pulse Biosciences, Inc. reported $751K of revenue over the trailing twelve months. 9 reported series are charted on this page, each one as filed.

$751K

Revenue, trailing twelve months · to Q1 2026 · every figure below is as filed, with no scoring applied

Net Income: −$75M
Net Income · +24% year on year · trailing twelve months to Q1 2026
Free Cash Flow: −$55M
Free Cash Flow · +38% year on year · trailing twelve months to Q1 2026

Every series Ryufin has for PLSE, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$751K	n/a	Q1 2026
Net Income	−$75M	+24%	Q1 2026
EPS	−$2.03	n/a	Q3 2022 · 14 quarters behind
Op Margin	−110461%	n/a	Q4 2020 · 21 quarters behind
Net Margin	−110411%	n/a	Q4 2020 · 21 quarters behind
ROE	−87%	n/a	Q1 2026
ROA	−73%	n/a	Q1 2026
ROIC	171162%	n/a	Q4 2023 · 9 quarters behind
Free Cash Flow	−$55M	+38%	Q1 2026